SCHEMBL821353

SCHEMBL821353

C[Si](C)(Cc1ccccc1)N([Nd](Br)N([Si](C)(C)Cc1ccccc1)[Si](C)(C)Cc1ccccc1)[Si](C)(C)Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TSHR P16473 2/20 0.35
TP53 P04637 1/20 0.34
TRPA1 O75762 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
AOC3 Q16853 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
CYP19A1 P11511 3/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL821913 0.80 CYP19A1 (0.36) ALDH1A1TSHRTP53TDP1KDM4E
SCHEMBL822285 0.80 ALDH1A1 (0.35) ALDH1A1TSHRTP53TDP1KDM4E
SCHEMBL821652 0.80 NR1H2 (0.37) ALDH1A1TSHRTP53TDP1KDM4E
SCHEMBL8777923 0.74 TSHR (0.46) PIM1ALDH1A1TSHRTP53CYP3A4
Hydrochloric Acid SCHEMBL821912 0.73 ALDH1A1 (0.37) ALDH1A1TSHRTP53TDP1KDM4E
SCHEMBL1107767 0.73 TP53 (0.48) ALDH1A1TSHRTP53TRPA1TDP1
SCHEMBL8970493 0.70 TSHR (0.46) ALDH1A1TSHRTP53TRPA1TDP1
SCHEMBL5514135 0.70 TSHR (0.46) ALDH1A1TSHRTP53TRPA1TDP1
Hydrochloric Acid SCHEMBL821914 0.69 ALDH1A1 (0.37) ALDH1A1TSHRTP53KDM4ECYP3A4
Bromide SCHEMBL821352 0.69 ALDH1A1 (0.37) ALDH1A1TSHRTP53TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153545-B2 Process for homo—or copolymerization of conjugated olefins STYRON EUROPE GMBH (CH) 2012-04-10 US disclosed
US-20110160041-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS STYRON EUROPE GMBH 2011-06-30 US disclosed
US-7915194-B2 Process for homo- or copolymerization of conjugated olefins STYRON EUROPE GMBH (CH) 2011-03-29 US disclosed
EP-2267046-A1 Process for homo- or copolymerization of conjugated olefines DOW GLOBAL TECHNOLOGIES INC. (US) 2010-12-29 EP disclosed
US-20100248947-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-09-30 US disclosed
US-7612009-B2 Process for homo-or copolymerization of conjugated olefines DOW GLOBAL TECHNOLOGIES, INC. (US) 2009-11-03 US disclosed
US-20060142145-A1 Process for homo-or copolymerization of conjugated olefines TRINSEO EUROPE GMBH (CH) 2006-06-29 US disclosed
EP-1597292-A2 PROCESS FOR HOMO- OR COPOLYMERIZATION OF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES INC. (US) 2005-11-23 EP disclosed
WO-2004076504-A2 PROCESS FOR HOMO- OR COPOLYMERIZATION OF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES, INC. (US) 2004-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160041-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS F12, ETFB, F2 PIM1 2331/4885ALDH1A1 3112/4885TSHR 4347/4885
US-20060142145-A1 Process for homo-or copolymerization of conjugated olefines ETFB, F12, F2 PIM1 2290/4885ALDH1A1 3114/4885TSHR 4233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.